Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Evangelos Terpos, MD PhD, Nikolaos Kanellias, MD, Eftathios Kastritis, Maria Gavriatopoulou, MD, Vassilis Koutoulidis, MD, Ioannis Ntanasis-Stathopoulos, MD, Aristea-Maria Papanota, MD, Despina Fotiou, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Panagiotis Malandrakis, MD, Tina Bagratuni, PhD, Maria Roussou, MD, Lia A. Moulopoulos, MD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4326.

https://doi.org/10.1182/blood-2019-123606

Published: 2019

Journal Articles

Differentiating Fat Embolism Syndrome Due to Bone Marrow Necrosis in Patients with Sickle Hemoglobinopathies from Thrombotic Thrombocytopenic Purpura (TTP)

Radhika Gangaraju, MD, Jori May, MD, Paul MacLennan, PhD, Vishnu V.B. Reddy, MD, Marisa B. Marques, MD

Blood (2018) 132 (Supplement 1): 1090.

https://doi.org/10.1182/blood-2018-99-112621

Published: 2018

Journal Articles

Secondary Polycythemia and the Risk of Venous Thromboembolism (VTE) Among Hospitalized Patients in the United States

Smith Giri, MBBS, Kathan Dilipbhai Mehta, MBBS, MPH, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 1427.

https://doi.org/10.1182/blood.V128.22.1427.1427

Published: 2016

Journal Articles

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Evangelos Terpos, Nikolaos Kanellias, Lia A Moulopoulos, Dimitrios Christoulas, Andreas Koureas, Tina Bagratuni, Vasilios Koutoulidis, Efstathios Kastritis, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3090.

https://doi.org/10.1182/blood.V122.21.3090.3090

Published: 2013

Journal Articles

Inferior Vena Cava Filters in Trauma Patients: A National Practice Pattern Survey of U.S. Trauma Centers

Anita Rajasekhar, MD, Hany Elmariah, MD, Darwin Ang, MD, MSc, PhD, Lawrence Lottenberg, MD, Rebecca Beyth, MD, MSc, Richard Lottenberg, MD

Blood (2012) 120 (21): 4249.

https://doi.org/10.1182/blood.V120.21.4249.4249

Published: 2012

Journal Articles

Do Sickle Cell Patients Wait Longer to See Physicians in the Emergency Department?

Carlton Haywood, Jr., PhD, MA, Rakhi Naik, MD, Mary Catherine Beach, MD, MPH, Sophie Lanzkron, MD, MHS

Blood (2011) 118 (21): 2070.

https://doi.org/10.1182/blood.V118.21.2070.2070

Published: 2011

Journal Articles

Efficacy of Low-Dose Recombinant Activated Factor VII (rFVIIa) in Massively Transfused Trauma Patients with Coagulopathy.

Karen Quillen, MD, Erwin Hirsch, MD, Graciela Bauza, MD

Blood (2005) 106 (11): 950.

https://doi.org/10.1182/blood.V106.11.950.950

Published: 2005

NARROW

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Differentiating Fat Embolism Syndrome Due to Bone Marrow Necrosis in Patients with Sickle Hemoglobinopathies from Thrombotic Thrombocytopenic Purpura (TTP)

Secondary Polycythemia and the Risk of Venous Thromboembolism (VTE) Among Hospitalized Patients in the United States

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Inferior Vena Cava Filters in Trauma Patients: A National Practice Pattern Survey of U.S. Trauma Centers

Do Sickle Cell Patients Wait Longer to See Physicians in the Emergency Department?

Efficacy of Low-Dose Recombinant Activated Factor VII (rFVIIa) in Massively Transfused Trauma Patients with Coagulopathy.

Email alerts

ASH Publications

American Society of Hematology

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Differentiating Fat Embolism Syndrome Due to Bone Marrow Necrosis in Patients with Sickle Hemoglobinopathies from Thrombotic Thrombocytopenic Purpura (TTP)

Secondary Polycythemia and the Risk of Venous Thromboembolism (VTE) Among Hospitalized Patients in the United States

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Inferior Vena Cava Filters in Trauma Patients: A National Practice Pattern Survey of U.S. Trauma Centers

Do Sickle Cell Patients Wait Longer to See Physicians in the Emergency Department?

Efficacy of Low-Dose Recombinant Activated Factor VII (rFVIIa) in Massively Transfused Trauma Patients with Coagulopathy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only